Ramos OCA, Garza AG, Rodríguez BI, Ábrego MV, Maltos VW

Language: Spanish
References: 15
Page: 161-164
PDF size: 68.94 Kb.

ABSTRACT

Objective. To study the effect of glutamine supplement in septic children could reduce the frequency of systemic inflammatory response syndrome (SIRS). Material and methods. Comparative clinical study done in septic a Pediatric Intensive Care Unit (PICU) in 15 critical in children with sepsis whom, beside the sepsis treatment, received oral supplements of glutamine and other group of 16 children with sepsis, with similar treatment that not received glutamine. During the treatment in all of them were done periodically leucocytes and platelets counts, and the length to stay on PICU and in the hospital was registrated. Results. There was not statistical differences in the leucocytes and platelets counts, length to stay on PICU and the hospital Conclusion. The use of glutamine supplement in critically ill children with sepsis does not make any difference in the treatment in children.

REFERENCES

1. Hall JC, Geoffrey D, Hall J, De Sousa R, Brennan L. A prospective randomized trial of enteral glutamine in critical illness. Intensive Care Medicine 2003; 29: 1710-16.

2. Karinch AM. Glutamine metabolism in sepsis and infection. J Nutrition 2001; 131 (Suppl): 2535-38.

3. Wischmeyer PE. Glutamine: Mode of action in critical illness. Crit Care Med 2007; 35 (Suppl): S541-S544.

4. Wischmeyer PR. Glutamine: Mode of action in critical illness. Crit Care Med 2007; 35(Suppl.): S541-S544.

5. Satoh J. Nutritional benefits of enteral alanyl-glutamine supplementation on rat small intestinal damage induced by cyclophosphamide. J Gastroenterol Hepatol 2003; 18: 719-725.

6. Heyland D. Immunonutrition in the critically ill: from old approaches to new paradigms. Intens Care Med 2005; 31: 501-3.

7. Garrel D. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: A prospective, controlled, randomized clinical trial. Crit Care Med 2003; 31: 2444-9.

8. Dilsiz A. Enteral glutamine supplementation and dexamethasone attenuate the local intestinal damage in rats with experimental necrotizing enterocolitis. Pediatr Surg Intern 2003: 19: 578-82.

9. Poindexter BB. Early provision of parenteral aminoacids in extremely low birth weight infants: Relation to growth and neurodevelopmental outcome. J Pediatr 2006; 148: 300-5.

10. Poindexter BB. Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants. Pediatrics 2004; 113: 1209-18.

11. Fredriksson K. Mitochondrial function in sepsis: Respiratory versus leg muscle. Crit Care Med 2007; 35(Suppl): S449-53.

12. Kaninch AM. Glutamine metabolism in sepsis and infection. J Nutrition 2001; 131(Suppl): 2535-8.

13. Vincent JLJ. Metabolic support in sepsis and multiple organ failure: More questions than answers. Crit Care Med 2007; 35: S436-S440.

14. Yang H. Bidirectional supply of glutamine maintains enterocyte ATP content in the in vitro using chamber model. Inter J Colorectal Dis 2000; 15: 291-6.

15. Inga TI. Exogenous glutamine-compensating a shortage? Crit Care Med 2007; 35 (Suppl): S553-S56.